| Literature DB >> 12750020 |
Lihua Zhao1, Nigel M Allanson, Samantha P Thomson, John K F Maclean, John J Barker, William U Primrose, Paul D Tyler, Ann Lewendon.
Abstract
Phosphopantetheine adenylyltransferase (PPAT) is an essential enzyme in Coenzyme A biosynthesis. Because bacterial PPAT and mammalian PPAT are dissimilar, this enzyme is an attractive antibacterial target. Based on the structure of the substrate, 4-phosphopantetheine, a dipeptide library was designed, synthesised and tested against Escherichia coli PPAT. The most potent inhibitor PTX040334 was co-crystallised with E. coli PPAT. With this structural information, a rational iterative medicinal chemistry program was initiated, aimed at increasing the number of inhibitor-enzyme interactions. A very potent and specific inhibitor, PTX042695, with an IC(50) of 6 nM against E.coli PPAT, but with no activity against porcine PPAT, was obtained.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12750020 DOI: 10.1016/s0223-5234(03)00047-3
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514